文献速递肺栓塞与肺血管病

儿童肺动脉高压血管病的PPHNet注册研究特征分析

Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry.
PubMed 文献 · Eur Respir J · 2021-12-31

基于PPHNet多中心注册的1475例患儿,按WSPH分类描述儿童肺动脉高压的疾病分布与临床特征。第1组和第3组最常见(分别45%和49%),第3组以支气管肺发育不良和先天性膈疝为主,且疾病缓解优于第1组。

要点

  • 儿童PH以WSPH第1组(45%)和第3组(49%)为主。
  • 第3组常见支气管肺发育不良和先天性膈疝。
  • 第3组疾病缓解优于第1组(HR 3.1;p<0.001)。

核心结论

  • 儿童PH中第3组疾病占比突出,反映发育性肺疾病相关PH的日益被认识。

研究设计与样本

  • 多中心注册研究,纳入PPHNet八个跨学科PH项目的1475例患儿。

主要发现

  • 第1组(PAH)和第3组(肺或低氧相关PH)分别占45%和49%。
  • 第3组最常见为支气管肺发育不良和先天性膈疝。
  • 第1组中60%与先天性心脏病相关,23%为特发性PAH。
  • 第3组较第1组疾病缓解更好(HR 3.1;p<0.001)。
  • 第3组诊断年龄更小(中位0.3 vs 1.6岁;p<0.001),男性更多(57% vs 45%;p<0.001)。

关键数值与推荐

  • Down综合征占整个PH队列的11%,为PPHNet注册中最常见的遗传综合征。

临床怎么用

  • 临床应重视发育性肺疾病相关PH(第3组)的识别与分型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are limited data about the range of diseases, natural history, age-appropriate end-points and optimal care for children with pulmonary hypertension (PH), including the need for developing high-quality patient registries of children with diverse forms of PH to enhance care and research. Our objective was to characterise the distribution and clinical features of diseases associated with paediatric PH, including natural history, evaluation, therapeutic interventions and outcomes, as defined by the World Symposium on Pulmonary Hypertension (WSPH) classification. METHODS: 1475 patients were enrolled into a multisite registry across the Pediatric Pulmonary Hypertension Network (PPHNet), comprised of eight interdisciplinary PH programmes. RESULTS: WSPH Groups 1 (pulmonary arterial hypertension (PAH)) and 3 (lung or hypoxia-related PH) were the most common primary classifications (45% and 49% of subjects, respectively). The most common Group 3 conditions were bronchopulmonary dysplasia and congenital diaphragmatic hernia. Group 1 disease was predominantly associated with congenital heart disease (60% of Group 1 cases) and idiopathic PAH (23% of Group 1 cases). In comparison with Group 1, Group 3 subjects had better disease resolution (hazard ratio 3.1; p<0.001), tended to be younger at diagnosis (median (interquartile range) age 0.3 (0.0–0.6) versus 1.6 (0.1–6.9) years; p<0.001) and were more often male (57% versus 45%; p<0.001). Down syndrome, the most common genetic syndrome in the PPHNet Registry, constituted 11% of the entire PH cohort. CONCLUSIONS: We find a striking proportion of paediatric PH patients with Group 3 disorders, reflecting the growing recognition of PH in diverse developmental lung diseases. Greater precision of clinical phenotyping based on disease-specific characterisation may further enhance care and research of paediatric PH. To characterise the clinical features of diseases associated with paediatric pulmonary hypertension, including natural history, evaluation and therapeutic interventions, longitudinal data from 1500 children from major PH programmes were analysed https://bit.ly/3ff3zjV

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Abman SH, Mullen MP, Sleeper LA, et al. Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. Eur Respir J. 2021. PMID: 34140292. doi:10.1183/13993003.03337-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。